Filing Details

Accession Number:
0001593968-21-001513
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-02 21:26:12
Reporting Period:
2021-05-20
Accepted Time:
2021-06-02 21:26:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1397702 Silk Road Medical Inc SILK Surgical & Medical Instruments & Apparatus (3841) 208777622
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1770191 S. Andrew Davis C/O Silk Road Medical, Inc.
1213 Innsbruck Drive
Sunnyvale CA 94089
Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-01 1,657 $1.60 32,897 No 4 M Direct
Common Stock Disposition 2021-06-01 1,657 $47.23 31,240 No 4 S Direct
Common Stock Acquisiton 2021-06-01 4,667 $4.73 35,907 No 4 M Direct
Common Stock Disposition 2021-06-01 4,667 $47.23 31,240 No 4 S Direct
Common Stock Acquisiton 2021-05-20 420 $40.38 31,660 No 5 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 5 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2021-06-01 1,657 $0.00 1,657 $1.60
Common Stock Option (right to buy) Disposition 2021-06-01 4,667 $0.00 4,667 $4.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,475 2016-01-03 2025-12-03 No 4 M Direct
79,592 2017-09-01 2027-11-30 No 4 M Direct
Footnotes
  1. The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020.
  2. This transaction was executed in multiple trades at price ranging from $46.67 to $48.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
  4. All of the shares subject to this option are fully vested and exercisable as of the date hereof.
  5. One forty-eighth of the shares subject to the option shall vest on September 1, 2017 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.